Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
Titel:
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
Auteur:
Molife, L.R. Attard, G. Fong, P.C. Karavasilis, V. Reid, A.H.M. Patterson, S. Riggs Jr, C.E. Higano, C. Stadler, W.M. McCulloch, W. Dearnaley, D. Parker, C. de Bono, J.S.